An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: Preliminary evaluation of targeting accuracy

Operative Neurosurgery

Volumn 70, Issue 1, 2012, Pages 95-103

  Larson, Paul S ^a   Starr, Philip A ^a   Bates, Geoffrey ^a   Tansey, Lisa ^a   Richardson, R Mark ^a   Martin, Alastair J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SurgiVision Inc   (United States)

Author keywords

Deep brain stimulation; Imaging phantoms; Interventional MRI; Magnetic resonance imaging; Stereotaxic techniques

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; CADAVER; COMPUTER ASSISTED SURGERY; COMPUTER PROGRAM; EVALUATION; HUMAN; IMAGE PROCESSING; INSTRUMENTATION; METHODOLOGY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT POSITIONING; STANDARD; STEREOTACTIC PROCEDURE; VALIDATION STUDY;

CADAVER; DEEP BRAIN STIMULATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; PATIENT POSITIONING; SOFTWARE; STEREOTAXIC TECHNIQUES; SURGERY, COMPUTER-ASSISTED;

EID: 84868608409     PISSN: 23324252     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31822f4a91     Document Type: Article

References (23)

1. Spiegel EA, Wycis HT, Marks M, Lee AJ. Stereotaxic apparatus for operations on the human brain. Science. 1947;106(2754):349-350.
2. Rahman M, Murad GJ, Mocco J. Early history of the stereotactic apparatus in neurosurgery. Neurosurg Focus. 2009;27(3):E12.
3. Henderson JM, Holloway KL, Gaede SE, Rosenow JM. The application accuracy of a skull-mounted trajectory guide system for image-guided functional neurosurgery. Comput Aided Surg. 2004;9(4):155-160.
4. Holloway KL, Gaede SE, Starr PA, Rosenow JM, Ramakrishnan V, Henderson JM. Frameless stereotaxy using bone fiducial markers for deep brain stimulation. J Neurosurg. 2005;103(3):404-413.
5. Tai CH, Wu RM, Lin CH, et al. Deep brain stimulation therapy for Parkinson's disease using frameless stereotaxy: comparison with frame-based surgery. Eur J Neurol. 2010;17(11):1377-1385.
6. Miga MI, Roberts DW, Hartov A, et al. Updated neuroimaging using intraoperative brain modeling and sparse data. Stereotact Funct Neurosurg. 1999; 72(2-4):103-106.
7. Carter TJ, Sermesant M, Cash DM, Barratt DC, Tanner C, Hawkes DJ. Application of soft tissue modelling to image-guided surgery. Med Eng Phys. 2005; 27(10):893-909.
8. Hall WA, Truwit CL. Intraoperative MR-guided neurosurgery. J Magn Reson Imaging. 2008;27(2):368-375.
9. Moriarty TM, Quinones-Hinojosa A, Larson PS, et al. Frameless stereotactic neurosurgery using intraoperative magnetic resonance imaging: stereotactic brain biopsy. Neurosurgery. 2000;47(5):1138-1145.
10. Hall WA, Liu H, Martin AJ, Maxwell RE, Truwit CL. Brain biopsy sampling by using prospective stereotaxis and a trajectory guide. J Neurosurg. 2001;94(1):67-71.
11. De Salles AA, Frighetto L, Behnke E, et al. Functional neurosurgery in the MRI environment. Minim Invasive Neurosurg. 2004;47(5):284-289.
12. Alexander E III, Moriarty TM, Kikinis R, Black P, Jolesz FM. The present and future role of intraoperative MRI in neurosurgical procedures. Stereotact Funct Neurosurg. 1997;68(1-4 pt 1):10-17.
13. Martin AJ, Larson PS, Ostrem JL, et al. Placement of deep brain stimulator electrodes using real-time high-field interventional magnetic resonance imaging. Magn Reson Med. 2005;54(5):1107-1114.
14. Starr PA, Martin AJ, Larson PS. Implantation of deep brain stimulator electrodes using interventional MRI. Neurosurg Clin N Am. 2009;20(2):193-203.
15. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg. 2010;112(3):479-490.
16. Martin AJ, Larson PS, Ostrem JL, Starr PA. Interventional magnetic resonance guidance of deep brain stimulator implantation for Parkinson disease. Top Magn Reson Imaging. 2009;19(4):213-221.
17. Martin AJ, Starr PA, Larson PS. Software requirements for interventional MR in restorative and functional neurosurgery. Neurosurg Clin N Am. 2009;20(2):179-186.
18. Martin AJ, Hall WA, Roark C, Starr PA, Larson PS, Truwit CL. Minimally invasive precision brain access using prospective stereotaxy and a trajectory guide. J Magn Reson Imaging. 2008;27(4):737-743.
19. Kaplitt MG, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 2007;369(9579):2097-2105.
20. Marks WJ Jr, Ostrem JL, Verhagen L, et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 2008;7(5):400-408.
21. Christine CW, Starr PA, Larson PS, et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009;73(20):1662-1669.
22. Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics. 2008;5(1):123-127.
23. Roskom J, Swistowski A, Zeng X, Lim DA. Future directions: use of interventional MRI for cell-based therapy of Parkinson disease. Neurosurg Clin N Am. 2009;20 (2):211-218.